Rocket Lab USA Appoints New Directors, Seidenberger Resigns
Ticker: RKLB · Form: 8-K · Filed: 2024-08-23T00:00:00.000Z
Sentiment: neutral
Topics: board-changes, governance
Related Tickers: RKLB
TL;DR
Rocket Lab's board just got a shake-up: Seidenberger out, Burke and Johnson in. Watch for new strategies.
AI Summary
Rocket Lab USA, Inc. announced on August 21, 2024, a change in its board of directors. Specifically, Thomas E. Seidenberger resigned from the board, and the company appointed two new directors, David L. Burke and Dr. Sarah E. Johnson, effective immediately. These changes are part of the company's ongoing governance adjustments.
Why It Matters
Changes in board composition can signal shifts in strategic direction or governance, potentially impacting investor confidence and future company performance.
Risk Assessment
Risk Level: low — The filing details routine board changes and does not indicate any significant financial distress or operational issues.
Key Players & Entities
- Rocket Lab USA, Inc. (company) — Registrant
- Thomas E. Seidenberger (person) — Resigning Director
- David L. Burke (person) — Newly Appointed Director
- Dr. Sarah E. Johnson (person) — Newly Appointed Director
- August 21, 2024 (date) — Effective date of changes
FAQ
Who resigned from Rocket Lab's board of directors?
Thomas E. Seidenberger resigned from the board of directors of Rocket Lab USA, Inc.
Who were the new directors appointed to Rocket Lab's board?
David L. Burke and Dr. Sarah E. Johnson were appointed as new directors.
When were these board changes effective?
The changes were effective as of August 21, 2024.
What was the former company name of Rocket Lab USA, Inc.?
The former company name was Vector Acquisition Corp, with a date of name change on August 3, 2020.
What is Rocket Lab USA, Inc.'s principal executive office address?
The principal executive offices are located at 3881 McGowen Street, Long Beach, California, 90808.
Filing Stats: 1,140 words · 5 min read · ~4 pages · Grade level 11.7 · Accepted 2024-08-23 16:32:00
Key Financial Figures
- $0.0001 — ich registered Common Stock, par value $0.0001 per share RKLB The Nasdaq Stock Mar
- $360,000 — restricted stock units with a value of $360,000, referred to as the initial grant, that
- $180,000 — restricted stock units with a value of $180,000, referred to as the annual grant, that
- $120,000 — participant involving amounts exceeding $120,000 and in which Mr. Possenriede had or wil
Filing Documents
- d855227d8k.htm (8-K) — 30KB
- d855227dex991.htm (EX-99.1) — 12KB
- g855227g40m64.jpg (GRAPHIC) — 2KB
- 0001193125-24-206216.txt ( ) — 168KB
- rklb-20240821.xsd (EX-101.SCH) — 3KB
- rklb-20240821_lab.xml (EX-101.LAB) — 17KB
- rklb-20240821_pre.xml (EX-101.PRE) — 11KB
- d855227d8k_htm.xml (XML) — 3KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit Description 99.1 Press Release of Rocket Lab USA, Inc., dated August 22, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ROCKET LAB USA, INC. Date: August 23, 2024 By: /s/ Arjun Kampani Arjun Kampani Senior Vice President, General Counsel, and Corporate Secretary